Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Share-based Compensation (IS): 2021-2024

Historic Share-based Compensation (IS) for Cellebrite DI (CLBT) over the last 3 years, with Jun 2024 value amounting to $6.6 million.

  • Cellebrite DI's Share-based Compensation (IS) rose 42.50% to $6.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $21.9 million, marking a year-over-year increase of 34.41%. This contributed to the annual value of $19.0 million for FY2023, which is 38.59% up from last year.
  • Cellebrite DI's Share-based Compensation (IS) amounted to $6.6 million in Q2 2024, which was up 15.08% from $5.7 million recorded in Q1 2024.
  • In the past 5 years, Cellebrite DI's Share-based Compensation (IS) registered a high of $6.6 million during Q2 2024, and its lowest value of $1.4 million during Q3 2021.
  • In the last 3 years, Cellebrite DI's Share-based Compensation (IS) had a median value of $4.5 million in 2023 and averaged $4.5 million.
  • Data for Cellebrite DI's Share-based Compensation (IS) shows a peak YoY soared of 144.04% (in 2022) over the last 5 years.
  • Quarterly analysis of 4 years shows Cellebrite DI's Share-based Compensation (IS) stood at $1.7 million in 2021, then soared by 128.00% to $3.8 million in 2022, then soared by 33.61% to $5.1 million in 2023, then spiked by 42.50% to $6.6 million in 2024.
  • Its last three reported values are $6.6 million in Q2 2024, $5.7 million for Q1 2024, and $5.1 million during Q4 2023.